Fintel reports that on December 13, 2024, Stifel initiated coverage of ResMed Inc. - Depositary Receipt () (ASX:RMD) with a Hold recommendation.
Fintel reports that on December 13, 2024, BMO Capital initiated coverage of O'Reilly Automotive (LSE:0KAB) with a Outperform recommendation.
Fintel reports that on December 13, 2024, Stifel initiated coverage of ResMed Inc. - Depositary Receipt () (OTCPK:RSMDF) with a Hold recommendation.
Discover why Zacks rates Universal Health Realty as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore UHT's strategic expansions, financial health and operational efficiency.
Discover why Zacks has given AstroNova a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Explore the company's eco-friendly printing innovations and operational efficiencies alongside challenges from rising debt.
Discover why Zacks, being the first on Wall Street to initiate the stock coverage, rates ImmuCell as "Neutral." Explore ImmuCell's market leadership, growth prospects and the game-changing potential of its mastitis treatment nearing FDA approval.
Discover why Zacks, being the first on Wall Street to initiate the stock coverage, rates Jones Soda as "Neutral." Explore how JSDA navigates opportunities with health-focused and cannabis-infused drinks despite financial challenges.
Discover why Zacks, being the first on Wall Street to initiate the stock coverage, rates NTWK as "Outperform." Explore NetSol's growth potential with major global contracts and innovative tech, positioning it for success in asset finance and leasing solutions.
Discover why Zacks has given NRC Health a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Dive into the company's AI innovations, strategic partnerships, and financial resilience, along with the challenges of revenue declines, rising debt and stiff competition.
Fintel reports that on November 22, 2024, B. Riley Securities initiated coverage of Viking Therapeutics (LSE:0VQA) with a Buy recommendation.
Fintel reports that on November 22, 2024, Wells Fargo initiated coverage of ON Semiconductor (WBAG:ONSE) with a Overweight recommendation.
Fintel reports that on November 18, 2024, Stephens & Co. initiated coverage of C4 Therapeutics (NasdaqGS:CCCC) with a Equal-Weight recommendation.
Fintel reports that on November 11, 2024, Loop Capital initiated coverage of Cadence Design Systems (NasdaqGS:CDNS) with a Buy recommendation.
Fintel reports that on November 11, 2024, Loop Capital initiated coverage of Marvell Technology (NasdaqGS:MRVL) with a Hold recommendation.
Fintel reports that on November 11, 2024, Loop Capital initiated coverage of Skyworks Solutions (WBAG:SWKS) with a Hold recommendation.
Fintel reports that on November 11, 2024, Loop Capital initiated coverage of Marvell Technology (WBAG:MRVL) with a Hold recommendation.
Find out why Zacks has issued an "Underperform" rating on Big 5, being the first on Wall Street to initiate coverage on the stock. Uncover the substantial challenges posed by sales declines, margin pressures, rising costs, and stiff competition for the retailer.
Fintel reports that on November 8, 2024, Stephens & Co. initiated coverage of Bicycle Therapeutics plc - Depositary Receipt () (NasdaqGS:BCYC) with a Equal-Weight recommendation.
Fintel reports that on November 8, 2024, Stephens & Co. initiated coverage of Pyxis Oncology (NasdaqGS:PYXS) with a Overweight recommendation.
Fintel reports that on November 7, 2024, Morgan Stanley initiated coverage of Allegro MicroSystems (NasdaqGS:ALGM) with a Equal-Weight recommendation.
Fintel reports that on November 4, 2024, Citigroup initiated coverage of Joint Stock Company Kaspi.kz - Depositary Receipt () (NasdaqGS:KSPI) with a Buy recommendation.
Fintel reports that on November 4, 2024, Piper Sandler initiated coverage of Nektar Therapeutics (NasdaqCM:NKTR) with a Overweight recommendation.
Fintel reports that on November 4, 2024, Bernstein initiated coverage of Tencent Music Entertainment Group (SEHK:1698) with a Outperform recommendation.